膠原病内科医向け– category –
-
SLS2 Trial
Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, para... -
SLS1 Trial 追加解析
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease Donald P. Tashkin, Robert Elashoff, Philip J. Clements, ... -
SLS1 Trial
Cyclophosphamide versus Placebo in Scleroderma Lung Disease Donald P. Tashkin, Robert Elashoff, Philip J. Clements, Jonathan Goldin, Michael D. Roth, Daniel ... -
GiACTA Trial
この論文のまとめ 一言で言うと：巨細胞性動脈炎（GCA）に対して、トシリズマブ（TCZ）（週1回または隔週）はいずれも寛解維持に有用で、グルココルチコイド減量効果も...
